Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Haemonetics (HAE) Tax Provisions (2016 - 2025)

Haemonetics has reported Tax Provisions over the past 17 years, most recently at $15.2 million for Q4 2025.

  • For Q4 2025, Tax Provisions rose 22.58% year-over-year to $15.2 million; the TTM value through Dec 2025 reached $51.7 million, up 49.17%, while the annual FY2025 figure was $44.4 million, 29.42% up from the prior year.
  • Tax Provisions for Q4 2025 was $15.2 million at Haemonetics, up from $12.6 million in the prior quarter.
  • Over five years, Tax Provisions peaked at $15.2 million in Q4 2025 and troughed at -$16.4 million in Q2 2021.
  • A 5-year average of $7.4 million and a median of $8.3 million in 2022 define the central range for Tax Provisions.
  • Biggest five-year swings in Tax Provisions: crashed 478.09% in 2021 and later soared 318.9% in 2025.
  • Year by year, Tax Provisions stood at $5.1 million in 2021, then soared by 83.18% to $9.3 million in 2022, then surged by 37.8% to $12.8 million in 2023, then dropped by 3.03% to $12.4 million in 2024, then increased by 22.58% to $15.2 million in 2025.
  • Business Quant data shows Tax Provisions for HAE at $15.2 million in Q4 2025, $12.6 million in Q3 2025, and $11.1 million in Q2 2025.